Although you wouldnt necessarily know it from the relative performance of other banks in its weight class, Farmers Capital (NASDAQ:FFKT) has taken some meaningful self-improvement steps over the last couple of years. These moves have put the company on a path toward better interest spreads, better efficiency ratios, and better growth prospects, all of which should support higher earnings and returns in the coming years.
The valuation argument isnt quite as clean as Id like it to be. The shares do look undervalued on the basis of near-term returns on equity and EPS/EPS growth, not to mention what the shares could fetch in a potential acquisition, but Id like to see a little more discount relative to my long-term earnings growth expectations. At worst, though, this looks like a decent buy that could reward investors if 2018 results come in a little stronger than expected.
A Small Player With A Valuable Niche
Farmers Capital is a small bank no matter how you look at it around $300 million in market cap, under $1.7 billion in assets, and just 34 branches in operation. But what Farmers Capital may lack in size, I believe it can compensate in value, as the bank has a respectable business in Kentuckys Golden Triangle (an area including Cincinnati, Lexington, and Louisville, with above-average population and income growth relative to the region).
Top Undervalued Stocks To Own Right Now: Synta Pharmaceuticals Corp.(SNTA)
- [By Lisa Levin]
Synta Pharmaceuticals Corp. (NASDAQ: SNTA) shares were also up, gaining 61 percent to $0.393. Synta Pharmaceuticals announced plans to merge with privately-held Madrigal Pharmaceuticals.
Top Undervalued Stocks To Own Right Now: Changyou.com Limited(CYOU)
- [By Rick Munarriz]
Continuing its turnaround may seem to be an applause-worthy event. This is the third quarter in a row that year-over-year revenue growth tops 20%. However, weak guidance and continuing softness in its flagship display advertising business are sending the stock that was hitting two-year highs just six months ago to fresh 10-year lows.Spun-off subsidiaries Sogou (NYSE:SOGO) and Changyou.com (NASDAQ:CYOU) are also moving lower on Wednesday.
- [By Lisa Levin]
Check out these big penny stock gainers and losers
Changyou.com Limited (NASDAQ: CYOU) fell 27.5 percent to $21.35 in pre-market trading.
Flex Ltd. (NASDAQ: FLEX) fell 19.7 percent to $13.36 in pre-market trading after a mixed fourth quarter report.
Tandem Diabetes Care, Inc. (NASDAQ: TNDM) shares fell 10.5 percent to $7.15 in pre-market trading following mixed Q1 results.
Eleven Biotherapeutics, Inc. (NASDAQ: EBIO) fell 8.1 percent to $2.16 in pre-market trading.
LogMeIn Inc (NASDAQ: LOGM) fell 8 percent to $110.05 in pre-market trading. LogMeIn reported upbeat earnings for its first quarter, but issued weak second quarter and FY18 earning guidance.
United States Steel Corporation (NYSE: X) fell 6.2 percent to $35.36 in pre-market trading following Q1 results.
Deutsche Bank Aktiengesellschaft (NYSE: DB) fell 5 percent to $13.63 in pre-market trading.
Sony Corporation (NYSE: SNE) shares fell 4.3 percent to $48.00 in pre-market trading after reporting Q4 results.
Colgate-Palmolive Company (NYSE: CL) shares fell 4 percent to $64.00 in pre-market trading. Colgate-Palmolive posted upbeat Q1 earnings, while sales missed estimates
Top Undervalued Stocks To Own Right Now: Aurinia Pharmaceuticals Inc(AUPH)
- [By Lisa Levin] Related NVCN 18 Biggest Mid-Day Losers For Wednesday Legal Overhangs Keep Ladenburg Neutral On Neovasc Despite Positive Tiara Clinical Data Boston Scientific closes Neovasc transaction (Seeking Alpha)
Related BSX Watch These 10 Huge Call Purchases In Monday Trade Wonderful Wearables Get Their Own ETF Boston Scientific closes Neovasc transaction (Seeking Alpha) Gainers
Neovasc Inc (US) (NASDAQ: NVCN) rose 17.3 percent to $2.65 in pre-market trading after the company reported the close of its $75 million transaction with Boston Scientific Corporation (NYSE: BSX).
aTyr Pharma Inc (NASDAQ: LIFE) shares rose 12.3 percent to $4.10 in pre-market trading after the company disclosed 'promising' signals in myopathies with Resolaris in exploratory trials.
Globus Maritime Ltd (NASDAQ: GLBS) shares rose 10.1 percent to $6.90 in pre-market trading after climbing 5.03 percent on Monday.
Aurinia Pharmaceuticals Inc (NASDAQ: AUPH) shares rose 9.9 percent to $3.00 in pre-market trading. Aurinia Pharmaceuticals appointed Lorin Jeffry “Jeff” Randall to its board and Chairman of the Audit Committee.
Ocean Rig UDW Inc. (NASDAQ: ORIG) shares rose 8.7 percent to $2.89 in pre-market trading after surging 19.82 percent on Monday.
Full House Resorts, Inc. (NASDAQ: FLL) shares rose 5.1 percent to $2.08 in pre-market trading after declining 1.98 percent on Monday.
Seadrill Ltd (NYSE: SDRL) rose 5.1 percent to $4.13 in pre-market trading after surging 3.15 percent on Monday.
Noble Corporation (NYSE: NE) rose 5.1 percent to $7.60 in pre-market trading after declining 5.37 percent on Monday.
Arbutus Biopharma Corp (NASDAQ: ABUS) rose 5.1 percent to $3.10 in pre-market trading. Arbutus issued additional data from its ARB-1467 Phase II
- [By Lisa Levin]
Aurinia Pharmaceuticals Inc (NASDAQ: AUPH) shares shot up 24 percent to $4.60 after the company disclosed that Voclosporin met 48-week remission endpoints.
- [By Todd Campbell]
After positive mid-stage trial data suggested earlier this year that it might be able to reshape the treatment of kidney failure in lupus patients, Aurinia Pharmaceuticals (NASDAQ:AUPH)has announced plans for a late-stage study that could eventually allow it to win regulatory OKs in the U.S., Europe, and Japan.